M. Domanski

发表

Renal Function and Effectiveness of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Chronic Stable Coronary Disease in the Prevention of Events with ACE inhibition (PEACE) Trial

S. Solomon, M. Pfeffer, B. Gersh, 2006, Circulation.

Angiotensin-converting-enzyme inhibition in stable coronary artery disease.

M. Pfeffer, B. Gersh, M. Rice, 2004, The New England journal of medicine.

A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure.

L. Lazzeroni, J. Carlquist, Jeffrey L. Anderson, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction.

M. Domanski, D. Dries, C. E. Davis, 1999, Circulation.

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Douglas L Packer, Daniel B Mark, D. Mark, 2005, The New England journal of medicine.

2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.

Akshay S. Desai, M. Landray, D. DeMets, 2018, Journal of the American College of Cardiology.

2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials

James E. Tcheng, Christopher J. White, Norman L. Stockbridge, 2018, Circulation.

The Primary Prevention of Sudden Death in Patients with Coronary Artery Disease

M. Domanski, A. Buxton, 1993, Annals of Internal Medicine.

Left Ventricular Assist Devices Improve Functional Class without Normalizing Peak Oxygen Consumption

M. Domanski, G. Sayer, M. Henzlova, 2015, ASAIO journal.

A potential clinical application of the end systolic pressure volume relationship to the treatment of heart failure.

M. Domanski, 1981, Medical hypotheses.

Evaluation of left ventricular performance using digital subtraction angiography.

M. Domanski, C. Partain, R. Price, 1983, The American journal of cardiology.

Emergency percutaneous cardiopulmonary bypass support in cardiogenic shock from acute myocardial infarction.

M. Domanski, F. Shawl, S. Punja, 1989, The American journal of cardiology.

Contents

Deepak L. Bhatt, V. Fuster, Lihui Zhao, 2020, Journal of the American College of Cardiology.

Failure of benefit and early hazard of bucindolol for Class IV heart failure.

Jeffrey L. Anderson, M. Domanski, W. Rogers, 2003, Journal of cardiac failure.

The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial.

M. Domanski, D. Follmann, P. Deedwania, 2003, Journal of the American College of Cardiology.

Prevention of sudden cardiac death: management considerations

M. Domanski, 2000, Current opinion in cardiology.

Effect of antithrombotic therapy on risk of sudden coronary death in patients with congestive heart failure.

B. Gersh, M. Domanski, D. Dries, 1997, The American journal of cardiology.

Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data

V. Fuster, M. Domanski, P. Serruys, 2018, The Lancet.

Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.

V. Fuster, M. Domanski, P. Serruys, 2018, Journal of the American College of Cardiology.

Opposing effects of β blockers and angiotensin-converting enzyme inhibitors on development of new-onset diabetes mellitus in patients with stable coronary artery disease.

Hajime Uno, Scott D. Solomon, H. Uno, 2011, The American journal of cardiology.

PREVENTION OF SUDDEN CARDIAC DEATH : A CURRENT PERSPECTIVE

M. Domanski, D. Exner, 1998 .

The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial.

B. Hoogwerf, M. Domanski, G. Knatterud, 1999, Atherosclerosis.

SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization in the FREEDOM Trial.

V. Fuster, M. Domanski, E. Ribeiro, 2018, Journal of the American College of Cardiology.

Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On Study.

Samin K. Sharma, V. Fuster, M. Domanski, 2019, Journal of the American College of Cardiology.

Pleiotropic effect of lovastatin, with and without cholestyramine, in the post coronary artery bypass graft (Post CABG) trial.

J. Fleg, M. Domanski, E. Braunwald, 2008, The American journal of cardiology.

The World of Pacing and Electropysiology: Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation

M. Ezekowitz, E. Benjamin, B. Gersh, 2001, Journal of Interventional Cardiac Electrophysiology.

Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation

M. Ezekowitz, E. Benjamin, B. Gersh, 2001, Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing.

large number of individuals with both elevated SBP and el- evated DBP) would be retrogressive.

M. Domanski, J. Neaton, J. Stamler, 2017 .

the BEST trial The effect of diabetes on outcomes of patients with advanced heart failure in

M. Domanski, D. Follmann, P. Deedwania, 2011 .

Clinical Investigations The Effect of Gender on Outcome in Digitalis-Treated Heart Failure Patients

J. Fleg, M. Domanski, M. Bristow, 2005 .

The effect of gender on outcome in digitalis-treated heart failure patients.

J. Fleg, M. Domanski, M. Bristow, 2005, Journal of cardiac failure.

Long-Term Trandolapril Treatment Is Associated With Reduced Aortic Stiffness: The Prevention of Events With Angiotensin-Converting Enzyme Inhibition Hemodynamic Substudy

Jean-Claude Tardif, Scott D. Solomon, Gary F. Mitchell, 2007, Hypertension.

Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular Dysfunction.

M. Domanski, D. Exner, D. Dries, 1999, Journal of the American College of Cardiology.

Beta blockade in congestive heart failure--the need for a definitive study.

M. Domanski, Eric J. Eichhorn, 1994, The American journal of cardiology.

Comparison of echocardiography and radionuclide angiography as predictors of mortality in patients with left ventricular dysfunction (studies of left ventricular dysfunction).

M. Domanski, I. Mirsky, D. Exner, 1999, The American journal of cardiology.

White blood cell count and mortality in patients with ischemic and nonischemic left ventricular systolic dysfunction (an analysis of the Studies Of Left Ventricular Dysfunction [SOLVD])

M. Domanski, D. Exner, M. Waclawiw, 1999, The American journal of cardiology.

Treatment of sudden cardiac death. Current understandings from randomized trials and future research directions.

M. Domanski, D. Zipes, E. Schron, 1997, Circulation.

The NHLBI Post-Coronary Artery Bypass Graft Clinical Trial (Post-CABG): angiographic outcomes

C. White, M. Domanski, N. Geller, 1996 .

Dual Antiplatelet Therapy in the Prevention of Recurrent Ischemic Events.

M. Domanski, 2016, Journal of the American College of Cardiology.

Geographic variability in patient characteristics, treatment and outcome in an International Trial of Magnesium in acute myocardial infarction.

E. Antman, S. Assmann, M. Domanski, 2004, Controlled clinical trials.

Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

D. Mark, M. Domanski, R. Boineau, 2007, American heart journal.

Central Clinical Research Issues in Electrophysiology: Report of the NASPE Committee

M. Ezekowitz, C. Tracy, M. Domanski, 2001, Pacing and clinical electrophysiology : PACE.

Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study

M. Domanski, A. Russo, A. Hallstrom, 2001 .

Survival of Antiarrhythmic or Implantable Cardioverter Defibrillator Treated Patients with Varying Degrees of Left Ventricular Dysfunction Who Survived Malignant Ventricular Arrhythmias

M. Domanski, A. Hallstrom, S. Saksena, 2002, Journal of cardiovascular electrophysiology.

Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction.

M. Domanski, J. Cohn, D. Exner, 2001, The New England journal of medicine.

A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure.

M. Domanski, P. Lavori, H. Krause-Steinrauf, 2001, The New England journal of medicine.

Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction.

M. Domanski, J. Cohn, D. Exner, 2001, The New England journal of medicine.

Effects of Angiotensin Converting Enzyme Inhibition in Patients With Stable Coronary Artery Disease: The Prevention of Events With Angiotensin Converting Enzyme Inhibition (PEACE) Trial: The PEACE Study Investigators

M. Pfeffer, B. Gersh, M. Rice, 2005 .

Correlation of Echocardiographic Normalized Peak Rate of Left Ventricular Area Expansion With Radionuclide Peak Filling Rate

M. Domanski, N. Nanda, R. Cunnion, 1995 .

Correlation of Echocardiographic Fractional Area Change with Radionuclide Left Ventricular Ejection Fraction

M. Domanski, N. Nanda, R. Cunnion, 1995 .

Cardiogenic shock: current understandings and future research directions.

E. Topol, M. Domanski, 1994, The American journal of cardiology.

Prognostic implications of troponin T and creatine kinase-MB elevation after coronary artery bypass grafting.

M. Domanski, 2012, American heart journal.

Frequency of aspirin resistance in a community hospital.

M. Domanski, A. Michelson, E. Peyster, 2006, The American journal of cardiology.

Usefulness of the subaortic diameter for normalizing left ventricular and left atrial dimensions.

M. Domanski, W. Roberts, R. Cunnion, 1991, The American journal of cardiology.

Association of Myocardial Enzyme Elevation and Survival Following Coronary Artery Bypass Graft Surgery

G. Hillis, M. Domanski, M. Mack, 2012 .

Evaluation of treatment strategies of malignant ventricular tachyarrhythmias in the era of the implantable defibrillator.

M. Domanski, S. Saksena, 1993, The American journal of cardiology.

Lessons from the post coronary artery bypass graft study in evaluating and controlling technical variability in angiographic trials. Post CABG Investigators.

B. Hoogwerf, C. White, M. Domanski, 2001, The American journal of cardiology.

Primary Prevention with Defibrillator Therapy in Women: Results from the Sudden Cardiac Death in Heart Failure Trial

D. Mark, M. Domanski, A. Russo, 2008, Journal of cardiovascular electrophysiology.

Clinical and socioeconomic profile of patients with malignant ventricular arrhythmias in 1993 to 1995. AVID investigators. Antiarrhythmics Versus Implantable Defibrillator.

M. Domanski, A. Hallstrom, S. Saksena, 1997, The American journal of cardiology.

Emergency Institution of Cardiopulmonary Bypass Support in Cardiogenic Shock

M. Domanski, F. Shawl, 1991 .

Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction.

M A Waclawiw, B. Gersh, M. Domanski, 1998, Journal of the American College of Cardiology.

Effect of statin therapy on survival in patients with nonischemic dilated cardiomyopathy (from the Beta-blocker Evaluation of Survival Trial [BEST]).

J. Fleg, M. Domanski, S. Coady, 2007, The American journal of cardiology.

Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes The

Samin K. Sharma, V. Fuster, M. Domanski, 2019 .

M. Domanski, M. Farkouh, M. Milojevic, 2018, Journal of the American College of Cardiology.

Reply: Stroke Risk Following Anaortic Off-Pump CABG Versus PCI.

M. Domanski, M. Farkouh, A. Kappetein, 2018, Journal of the American College of Cardiology.

Detection of high-risk atherosclerotic plaque: report of the NHLBI Working Group on current status and future directions.

Jacques Ohayon, Guillermo J Tearney, Juan F Granada, 2012, JACC. Cardiovascular imaging.

Next Steps in Primary Prevention of Coronary Heart Disease: Rationale for and Design of the ECAD Trial.

Muhammad Mamdani, Francisco Diaz-Mitoma, Valentin Fuster, 2015, Journal of the American College of Cardiology.

Type 1 Diabetes, Coronary Disease Complexity, and Optimal Revascularization Strategy.

M. Domanski, M. Farkouh, 2017, Journal of the American College of Cardiology.

Impact of amiodarone versus implantable cardioverter defibrillator therapy on the mode of death in congestive heart failure patients in the SCDHeFT trial

M. Walsh, M. Domanski, D. Packer, 2005 .

Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD).

M. Domanski, B. Pitt, E. Peyster, 2003, Journal of the American College of Cardiology.

Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators.

M. Brodsky, M. Domanski, A. Hallstrom, 1999, Journal of the American College of Cardiology.

A sensitive cardiac troponin T assay in stable coronary artery disease.

M. Pfeffer, B. Gersh, M. Rice, 2009, The New England journal of medicine.

Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus.

M. Domanski, D. Follmann, P. Pizzo, 1995, The Journal of pediatrics.

Racial differences in the outcome of left ventricular dysfunction.

B. Gersh, M. Domanski, D. Exner, 1999, The New England journal of medicine.

Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study.

M. Domanski, A. Russo, A. Hallstrom, 1998, American heart journal.

On "Alert" for Acute Coronary Syndromes.

M. Domanski, 2019, Journal of the American College of Cardiology.

Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.

M. Pfeffer, M. Rice, K. Jablonski, 2007, Journal of the American College of Cardiology.

Reply: Readmissions and Diuretic Dosing.

P. Austin, M. Domanski, J. Spertus, 2017, JACC. Heart failure.

Prognostic Significance of the Centers for Disease Control/American Heart Association High-Sensitivity C-Reactive Protein Cut Points for Cardiovascular and Other Outcomes in Patients With Stable Coronary Artery Disease

M. Pfeffer, P. Ridker, B. Gersh, 2007, Circulation.

Fatal cor pulmonale caused by extensive tumor emboli in the small pulmonary arteries without emboli in the major pulmonary arteries or metastases in the pulmonary parenchyma.

M. Domanski, W. Roberts, R. Cunnion, 1993, The American journal of cardiology.

Primary sarcoma of the heart causing mitral stenosis.

M. Domanski, W. Roberts, D. Kleiner, 1990, The American journal of cardiology.

Sudden cardiac death prevention: antiarrhythmic drugs and the implantable cardioverter-defibrillator.

M. Domanski, 1995, Journal of interventional cardiology.

Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors. NHLBI post coronary artery bypass graft clinical trial. Post CABG Trial Investigators.

N L Geller, S A Forman, B. Hoogwerf, 1999, Circulation.

Delayed progression of atherosclerosis in coronary bypass grafts is similar in women compared to men following aggressive cholesterol lowering despite more frequent risk factors: post CABG trial

B. Hoogwerf, C. White, M. Domanski, 1998 .

Bethesda Conference: conference for the design of clinical trials to study circulatory support devices for chronic heart failure.

O. Howard Frazier, Bartley P. Griffith, George J. Magovern, 1998, The Annals of thoracic surgery.

Evaluation of an Implantable Ventricular Assist System for Humans With Chronic Refractory Heart Failure

B. Griffith, M. Domanski, D. Pennington, 1995 .

Atlas of Transesophageal Echocardiography

M. Domanski, N. Nanda, 1998 .

Rationale, design, and methods of the Action to Control Cardiovascular Risk in Diabetes Eye Study (ACCORD-EYE).

W. Ambrosius, M. Domanski, E. Chew, 2007, The American journal of cardiology.

Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policy.

Joshua R. Smith, R. Califf, E. Fain, 2007, American heart journal.

Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study

M. Domanski, N. Geller, Y. Rosenberg, 2004, Circulation.

A comparison of rate control and rhythm control in patients with atrial fibrillation.

A L Waldo, H L Greene, M. Domanski, 2002, The New England journal of medicine.

Late effects in long-term survivors of high-grade non-Hodgkin's lymphomas.

M. Domanski, I. Magrath, M. Datiles, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk.

V. Fuster, Lihui Zhao, M. Domanski, 2020, Journal of the American College of Cardiology.

The metabolic syndrome.

M. Domanski, M. Proschan, 2004, Journal of the American College of Cardiology.

Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction.

M. Pfeffer, M. Domanski, B. Pitt, 1999, Journal of the American College of Cardiology.

Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.

S. Connolly, M. Domanski, R. Cappato, 2000, European heart journal.

Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.

B. Gersh, M. Domanski, N. Geller, 2005, American heart journal.

Isolated systolic hypertension : prognostic information provided by pulse pressure.

B R Davis, B. Davis, M. Pfeffer, 1999, Hypertension.

Adjunctive Renal Sympathetic Denervation to Modify Hypertension as Upstream Therapy in the Treatment of Atrial Fibrillation (H‐FIB) Study: Clinical Background and Study Design

M. Domanski, A. Moskowitz, V. Reddy, 2013, Journal of cardiovascular electrophysiology.

Standardized Definitions for Cardiovascular and Stroke Endpoint Events in Clinical Trials

Akshay S. Desai, Brian J. McCourt, M. Landray, 2014 .

Can we dramatically reduce the incidence of coronary heart disease?

V. Fuster, M. Domanski, S. Grundy, 2011, Nature Reviews Cardiology.

The epidemiology of atrial fibrillation.

M. Domanski, M J Domanski, 1995, Coronary artery disease.

Lipoprotein(a) for risk assessment in patients with established coronary artery disease.

S. Solomon, M. Domanski, M. Sabatine, 2014, Journal of the American College of Cardiology.

Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery.

V. Hasselblad, G. Hillis, M. Domanski, 2011, JAMA.

A polymorphism within a conserved β1-adrenergic receptor motif alters cardiac function and β-blocker response in human heart failure

L. Lazzeroni, J. Carlquist, Jeffrey L. Anderson, 2006 .

Factor VIII Products and Inhibitors in Severe Hemophilia A

V. Fuster, M. Domanski, M. Farkouh, 2013 .

Relative role of meta-analysis and randomized controlled trials in the assessment of medical therapies.

M. Domanski, L. Friedman, 1994, The American journal of cardiology.

Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials.

M. Domanski, Y. Rosenberg, D. Dries, 1997, Journal of the American College of Cardiology.

Evaluation of an implantable ventricular assist system for humans with chronic refractory heart failure. Study overview. LVAS Study Group. Left Ventricular Assist System.

B. Griffith, M. Domanski, D. Pennington, 1995, ASAIO journal.

Strategies for multivessel revascularization in patients with diabetes.

Akshay S. Desai, Sameer Bansilal, George Dangas, 2012, The New England journal of medicine.

Histopathology of renal failure after heart transplantation: a diverse spectrum.

M. Domanski, S. Dikman, A. Nair, 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Prognostic Utility of Lipoprotein-Associated Phospholipase A2 for Cardiovascular Outcomes in Patients With Stable Coronary Artery Disease

S. Solomon, M. Rice, M. Domanski, 2007, Arteriosclerosis, thrombosis, and vascular biology.

Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial.

V. Fuster, M. Domanski, G. Dangas, 2008, American heart journal.

Diuretic use, progressive heart failure, and death in patients in the DIG study.

M. Domanski, B. Pitt, M. Haigney, 2006, Journal of cardiac failure.

Implantable Devices Benefit Patients With Cardiovascular Diseases

M. Domanski, E. Schron, 2003, The Journal of cardiovascular nursing.

Heart failure with preserved systolic function

M. Domanski, E. Peyster, 2005, Current treatment options in cardiovascular medicine.

β-blockers in heart failure: recently completed and ongoing clinical trials

M. Domanski, D. Exner, D. Mcareavey, 2000, Expert opinion on investigational drugs.

The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction.

M. Domanski, L. Stevenson, D. Exner, 2000, Journal of the American College of Cardiology.

Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document

P. Ponikowski, S. Solomon, I. Piña, 2013, European journal of heart failure.

Acute ST-segment elevation myocardial infarction and prior stroke: an analysis from the Magnesium in Coronaries (MAGIC) trial.

E. Antman, S. Assmann, M. Domanski, 2004, American heart journal.

Percutaneous cardiopulmonary bypass support in the catheterization laboratory: technique and complications.

M. Domanski, F. Shawl, M. Davis, 1990, American heart journal.

Percutaneous cardiopulmonary bypass support in high-risk patients undergoing percutaneous transluminal coronary angioplasty.

M. Domanski, F. Shawl, S. Punja, 1989, The American journal of cardiology.

Emergency cardiopulmonary bypass support in patients with cardiac arrest in the catheterization laboratory.

M. Domanski, F. Shawl, S. Punja, 1990, Catheterization and cardiovascular diagnosis.

Antiarrhythmics Versus Implantable Defibrillators (AVID)--rationale, design, and methods.

M. Domanski, D. Wyse, A. Hallstrom, 1995, The American journal of cardiology.

Does preoperative coronary revascularization before noncardiac surgery reduce the risk of coronary events in patients with known coronary artery disease?

K. Eagle, M. Domanski, S. Ellis, 1995, The American journal of cardiology.

E ffects of Aggressive Cholesterol Lowering and Low-Dose Anticoagulation on Clinical and Angiographic Outcomes in Patients With Diabetes The Post Coronary Artery Bypass Graft Tr i a l

B. Hoogwerf, C. White, M. Domanski, 1999 .

Prevalence and predictors of heart failure with preserved systolic function: community hospital admissions of a racially and gender diverse elderly population.

M. Domanski, E. Peyster, J. Norman, 2004, Journal of cardiac failure.

Cardiovascular Risk Assessment Using Pulse Pressure in the First National Health and Nutrition Examination Survey (NHANES I)

M. Pfeffer, M. Domanski, M Domanski, 2001, Hypertension.

Association of Incident Cardiovascular Disease With Time Course and Cumulative Exposure to Multiple Risk Factors.

M. Domanski, D. Jacobs, D. Lloyd‐Jones, 2023, Journal of the American College of Cardiology.

A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS.

M. Domanski, Y. Rosenberg, D. Follmann, 2003, Journal of cardiac failure.

Influence of Albuminuria on Cardiovascular Risk in Patients With Stable Coronary Artery Disease

S. Solomon, M. Pfeffer, B. Gersh, 2007, Circulation.

Prognosis in Congestive Heart Failure

S. Yusuf, M. Domanski, R. Garg, 1994 .

Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials.

M. Pfeffer, M. Domanski, N. Geller, 1999, Journal of the American College of Cardiology.

Beta-blocker Evaluation of Survival Trial

M. Domanski, Michael J. Domanski, 2000 .

Effect of Baseline or Changes in Adrenergic Activity on Clinical Outcomes in the &bgr;-Blocker Evaluation of Survival Trial

M. Domanski, P. Lavori, S. Krueger, 2004, Circulation.

Prognostic Significance of Post-CABG Enzyme Elevations.

M. Domanski, M. Farkouh, 2017, Anesthesia and analgesia.

Relation of Post-Coronary Artery Bypass Graft Creatine Kinase-MB Elevations and New Q Waves With Long-Term Cardiovascular Death in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease.

V. Fuster, M. Domanski, K. Mahaffey, 2016, The American journal of cardiology.

Light-to-moderate alcohol consumption and prognosis in patients with left ventricular systolic dysfunction.

M. Domanski, D. Exner, H. Cooper, 2000, Journal of the American College of Cardiology.

Hypothesis: Catheter-based renal sympathetic denervation should be the initial therapy for essential hypertension.

M. Domanski, J. R. Lakhanpal, 2012, Medical hypotheses.

Risk factor control for coronary artery disease secondary prevention in large randomized trials.

V. Fuster, M. Domanski, R. Frye, 2013, Journal of the American College of Cardiology.

Obesity and cardiovascular events in patients with established coronary disease.

M. Rice, K. Jablonski, M. Domanski, 2006, European heart journal.

Catheter ablation of atrial fibrillation: A treatment frontier

M. Domanski, A. Waldo, 2006, Journal of Interventional Cardiac Electrophysiology.

Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial.

V. Fuster, M. Domanski, G. Dangas, 2014, Journal of the American College of Cardiology.

Associations Between Short or Long Length of Stay and 30-Day Readmission and Mortality in Hospitalized Patients With Heart Failure.

P. Austin, M. Domanski, J. Spertus, 2017, JACC. Heart failure.

Predictors of stroke associated with coronary artery bypass grafting in patients with diabetes mellitus and multivessel coronary artery disease.

V. Fuster, M. Domanski, M. Farkouh, 2015, The American journal of cardiology.

PREDICTORS OF STROKE ASSOCIATED WITH CORONARY ARTERY BYPASS GRAFTING IN PATIENTS WITH DIABETES AND MULTIVESSEL CORONARY ARTERY DISEASE

M. Domanski, 2014 .

Pulse pressure and cardiovascular disease-related mortality: follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT).

M. Pfeffer, M. Domanski, G. Mitchell, 2002, JAMA.

Prognostic factors for atherosclerosis progression in saphenous vein grafts: the postcoronary artery bypass graft (Post-CABG) trial. Post-CABG Trial Investigators.

N L Geller, B. Hoogwerf, C. White, 2000, Journal of the American College of Cardiology.

The progression of congestive heart failure over the course of the sudden cardiac death in heart failure trial (SCD-HeFT)

D. Mark, M. Domanski, R. Boineau, 2005 .

Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease.

S. Solomon, M. Pfeffer, M. Domanski, 2013, Journal of the American College of Cardiology.

Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial.

B. Hoogwerf, C. White, M. Domanski, 1999, Diabetes.

Procedural results and early clinical outcome of percutaneous transluminal myocardial revascularization.

U Kaul, M. Domanski, U. Kaul, 1999, The American journal of cardiology.

Optimization of pulsatile flow for mechanical circulatory support.

M. Domanski, D. Giddens, 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Association of Cumulative Systolic Blood Pressure With Long-Term Risk of Cardiovascular Disease and Healthy Longevity: Findings From the Lifetime Risk Pooling Project Cohorts.

M. Domanski, D. Lloyd‐Jones, C. Wu, 2020, Hypertension.

Abstract 20356: Comparison of CABG versus PCI Outcomes in Diabetic, Mutivessel Coronary Artery Disease Patients With and Without Acute Coronary Syndromes

V. Fuster, M. Domanski, M. Farkouh, 2014 .

Echocardiographic determination of left ventricular function.

M. Domanski, N. Nanda, 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entry.

Sameer Bansilal, George Dangas, Krishnan Ramanathan, 2012, American heart journal.

Determinants and prognostic information provided by pulse pressure in patients with coronary artery disease undergoing revascularization. The Balloon Angioplasty Revascularization Investigation (BARI).

M. Domanski, D. Faxon, B. Pitt, 2001, The American journal of cardiology.

Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Michael E. Miller, M. Domanski, D. Simons-Morton, 2007, The American journal of cardiology.